2024
Daily glucose variability is associated with intrahepatic fat content, β cell sensitivity, and biomarkers of glycolysis in youth with obesity
Barbieri E, Bonet J, Fox D, Nelson R, Nelson M, Nelson L, Fernandez C, Van Name M, Samuels S, Caprio S, Sabati M, Galderisi A, Sherr J, Man C, Santoro N. Daily glucose variability is associated with intrahepatic fat content, β cell sensitivity, and biomarkers of glycolysis in youth with obesity. Obesity 2024, 33: 116-124. PMID: 39658509, PMCID: PMC11666407, DOI: 10.1002/oby.24175.Peer-Reviewed Original ResearchConceptsIntrahepatic fat contentDaily glucose variabilityLiver proton density fat fractionProton density fat fractionGlucose variabilityInsulin sensitivityOral glucose tolerance testFat fractionInsulin secretionAssociated with insulin resistanceFirst-phase insulin secretionAssociated with 2-h glucoseGlucose tolerance testGlucose standard deviationMagnetic resonance imagingOral minimal modelCoefficient of variationBasal insulin secretionPediatric obesityPostprandial glucoseTolerance testCell sensitivityInsulin resistanceObesityResonance imaging
2017
Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer
Wali VB, Langdon CG, Held MA, Platt JT, Patwardhan GA, Safonov A, Aktas B, Pusztai L, Stern DF, Hatzis C. Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer. Cancer Research 2017, 77: 566-578. PMID: 27872098, PMCID: PMC5582957, DOI: 10.1158/0008-5472.can-16-1901.Peer-Reviewed Original ResearchConceptsTriple-negative breast cancerTNBC cell linesPairwise drug combinationsClinical translationAggressive diseaseCombination therapyBreast cancerPreclinical proofDrug combinationsCombination treatmentInvestigational drugsSingle agentSensitivity patternCell sensitivityCell linesTherapyApoptotic activityAnticancer activityDownregulated genesMitogenic signalingCrizotinibBlockadeClinicAgentsCancer
1996
Class I-like CD1A-C Do Not Protect Target Cells from NK-Mediated Cytolysis
Storkus W, Wei M, Cresswell P, Dawson J. Class I-like CD1A-C Do Not Protect Target Cells from NK-Mediated Cytolysis. Cellular Immunology 1996, 167: 154-156. PMID: 8548840, DOI: 10.1006/cimm.1996.0020.Peer-Reviewed Original ResearchConceptsClass INatural killer cell-mediated cytolysisTarget cellsCell-mediated cytolysisTarget cell susceptibilityNonclassical MHC class IHLA class ITarget cell sensitivityMHC class INatural killingNK cellsCD1c moleculesElevated expressionCell susceptibilityCell sensitivityCD1aCytolysisNKClonal transfectantsRelevant levelsCellsCell surfaceLysisPrevious studiesCD1b
1989
Adenovirus Inversely Modulates Target Cell Class I Antigen Expression and Sensitivity to Natural Killing
Storkus W, Cresswell P, Patterson E, Dawson J. Adenovirus Inversely Modulates Target Cell Class I Antigen Expression and Sensitivity to Natural Killing. 1989, 152-155. DOI: 10.1007/978-3-662-39946-0_40.Peer-Reviewed Original ResearchAntibody-dependent cellular cytotoxicityComplement-mediated cytolysisNatural killingClass INatural killer cell-mediated cytolysisMajor histocompatibility complex restrictionNK effector cellsI Antigen ExpressionCell-mediated cytolysisMHC class INK sensitiveNK cellsEffector cellsAntigen expressionCellular cytotoxicityViral specificityAdenovirus infectionTarget cellsComplex restrictionCell sensitivityNKRecent evidenceCytolysisCellsKilling
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply